Discovery of glycocholic acid and taurochenodeoxycholic acid as phenotypic biomarkers in cholangiocarcinoma

Although several biomarkers can be used to distinguish cholangiocarcinoma (CCA) from healthy controls, differentiating the disease from benign biliary disease (BBD) or pancreatic cancer (PC) is a challenge. CCA biomarkers are associated with low specificity or have not been validated in relation to...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Won-Suk, Park, Hae-Min, Ha, Jung Min, Shin, Sung Gyu, Park, Han-Gyu, Kim, Joonwon, Zhang, Tianzi, Ahn, Da-Hee, Kim, Sung-Min, Yang, Yung-Hun, Jeong, Jae Hyun, Theberge, Ashleigh B., Kim, Byung-Gee, Lee, Jong Kyun, Kim, Yun-Gon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6056462/
https://www.ncbi.nlm.nih.gov/pubmed/30038332
http://dx.doi.org/10.1038/s41598-018-29445-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6056462/
https://www.ncbi.nlm.nih.gov/pubmed/30038332
http://dx.doi.org/10.1038/s41598-018-29445-z

Ejemplares similares